• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

blog

Mexico proposes changes to medical device regulations in 2018

February 14, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group Mexican regulators are in the early stages of revising various elements of the country’s sanitary registration process for medical devices, including classification, biocompatibility and technovigilance. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Chinese FDA updates recall process for medical devices

February 13, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group Medical device regulators at the China Food and Drug Administration (CFDA) have issued a new provision on its recall process for defective devices. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those […]

Filed Under: Food & Drug Administration (FDA) Tagged With: blog, Emergo Group

New Indian medical device regulations for 2017

February 9, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group The Indian government is planning a significant overhaul of its system for regulating medical devices and IVDs. Emergo is still analyzing the new Medical Device Rules 2017 to determine how the new regulations will affect registration requirements in India, but we can now report on some general points found in […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Brazilian regulators drop medical device fees

February 8, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group Brazilian medical device market regulators plan to officially reduce registration and quality inspection fees for medical device companies after the country’s Ministry of Finance attempted to push through a hefty increase of those fees in 2015. Get the full story here at the Emergo Group’s blog. The opinions expressed in […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

Brazilian regulators add two firms to MDSAP medical device quality inspection program

February 7, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has added two more firms to its list of accredited inspectorsfor the Medical Device Single Audit Program (MDSAP). Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

New medical device rules from Indian regulators

February 6, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group India’s Ministry of Health and Family Welfare has released long-awaited new medical device and in vitro diagnostic (IVD) regulations that take effect in January 2018. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily […]

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

5 key takeaways from Emergo’s medical device industry outlook

February 2, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group Emergo’s latest survey of more than 3,000 medical device industry participants finds renewed focus among companies on US and European markets, as well as more bearish expectations for BRIC markets and greater challenges addressing regulatory compliance. Get the full story here at the Emergo Group’s blog. The opinions expressed in […]

Filed Under: Business/Financial News Tagged With: blog, Emergo Group

FDA offers Pre-RFD program for combination products

February 1, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group The US Food and Drug Administration has issued new draft guidance clarifying the agency’s Pre-Request for Designation (Pre-RFD) process whereby combination product manufacturers may request initial feedback regarding classification and regulatory oversight questions. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post […]

Filed Under: Food & Drug Administration (FDA) Tagged With: blog, Emergo Group

Does your medical device and IVD sales need an import license in India?

January 30, 2017 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group India’s medical device registration system is still transitioning to a more formalized and predictable framework, which has raised questions from foreign manufacturers about what regulators do and do not currently require for market authorization in the country. In many cases, one requirement foreign firms can be sure of is the […]

Filed Under: Policy Tagged With: blog, Emergo Group

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 30
  • Page 31
  • Page 32

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS